ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized 'Living Drug' trial targets Tough-to-Treat kidney cancer
Disease control OngoingThis study is testing a new cell therapy called AB-2100 for people with advanced kidney cancer that has come back or spread after standard treatments. Doctors take a patient's own immune cells, genetically modify them to better recognize and attack cancer, and infuse them back in…
Matched conditions: ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Arsenal Biosciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Experimental cell treatment offers hope for tough kidney cancers
Disease control OngoingThis early-stage trial is testing a new cell therapy called ALLO-316 for people with advanced kidney cancer that has spread. Researchers want to find the safest and most effective dose by giving patients different amounts of the treatment after they receive chemotherapy. The stud…
Matched conditions: ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC